VC Funds Starting with A

Angel Ventures is the first professionally managed angel investor network in Latin America, founded in August 2008 in Mexico City. One of the region's most active and influential venture firms, Angel Ventures leads Series Seed and Series A rounds in startups building innovative business models for the Latin American market. Fund I closed at $20 million in 2012, backing 21 companies; Fund II targeted $120 million to expand across the Pacific Alliance countries — Chile, Colombia, Mexico, and Peru. The Inter-American Development Bank (IDB) is among the fund's limited partners. With 110 total investments and a network of 300 co-investing angel members, Angel Ventures covers a broad range of sectors: fintech, e-commerce, healthtech, agribusiness, food technology, AI, and media. The team of 23 includes seven partners, one venture partner, and nine principals operating across Mexico and the United States. Typical check sizes range from $100K to $3 million, with the firm leading rounds at both seed and Series A stages. As a pioneer of the LatAm venture ecosystem, Angel Ventures has spent nearly two decades building the infrastructure that modern Latin American venture capital relies on — angel co-investment networks, institutional fund structures, and the cross-border relationships that connect Mexican and regional founders to global capital. The firm's combination of institutional discipline and deep regional knowledge makes it one of the formative forces in Latin American technology investing.

AngelBay is an angel investment network based in Gurugram, India, founded in 2020 by Piush Goyal, Shweta Agarwal, and Sorabh Agarwal. The firm focuses on early-stage startups, primarily investing at the seed and Series A stages. AngelBay's investments span a range of industries, including fintech, retail, healthcare, and enterprise applications. Their portfolio includes around 27 companies, with recent investments in startups like FinQY and Amocare. AngelBay not only offers capital but also provides strategic guidance to help startups scale. They are known for co-investing alongside other prominent networks like Venture Catalysts and Faad Network, highlighting their collaborative approach to venture funding. With a strong focus on the Indian startup ecosystem, AngelBay has also participated in deals in international markets such as France. The network is highly active, having made 78 investments to date, with notable exits like TABLT Pharmacy and InstaOffice. AngelBay's mission is to support founders in transforming existing markets and building sustainable businesses through hands-on involvement and strategic partnerships.

Angeleno Group, founded in 2001 and based in Los Angeles, is a venture capital firm specializing in growth capital for next-generation clean energy and climate solutions companies. With a strategic focus on sectors such as renewable energy, energy storage, sustainable mobility, and carbon mitigation, Angeleno Group aims to address critical global challenges posed by climate change. The firm leverages its extensive industry experience and longstanding relationships to support high-growth, innovative businesses. Angeleno Group invests opportunistically, typically deploying between $10 million and $30 million per opportunity, and focuses on companies with proven technologies and established customer traction. Their portfolio includes a diverse array of companies such as Fictiv, Span, and Anza RE, highlighting their commitment to fostering sustainable and transformative technologies. Angeleno Group's investment strategy is deeply rooted in creating value through active engagement with portfolio companies, providing support in product development, business strategy, sales, and corporate finance. The firm's approach is sector-focused, research-driven, and designed to build a diversified and high-return portfolio.

Angeles Investors is a Chicago-based venture firm that focuses on finding, funding, and growing Hispanic and Latino-led ventures. Founded in 2020, the firm is dedicated to supporting early-stage startups driven by Hispanic and Latinx entrepreneurs across various industries. Angeles Investors typically makes investments in sectors like SaaS, fintech, media, and AI, with portfolio companies including TackleAI, Sigo Seguros, and Poppy. The firm operates as an angel investment group, providing accredited investors with opportunities to network and invest in high-potential startups. Their members gain access to exclusive deals and board positions, helping to shape the direction of the businesses they support. Angeles Investors typically writes checks starting at $5,000, allowing for a low entry point into startup investing. Their investment strategy focuses on supporting scalable business models that are innovative and positioned for high growth, often targeting industries that are ripe for disruption. Angeles Investors also holds annual events like the Angeles 100 Awards, recognizing standout startups from their portfolio. Through its community and resources, Angeles is working to elevate underrepresented founders while generating impactful investment returns.

AngeliCo Ventures is a London-based venture capital firm and investment banking boutique founded in 2008. The firm specializes in healthcare, life sciences, and technology investments, targeting seed to growth-stage companies. AngeliCo Ventures focuses on sectors including digital health, therapeutics, diagnostics, medical devices, robotics, clean energy, and alternative care. The firm is known for its integrated strategy and investment banking solutions, offering services such as capital markets, mergers and acquisitions, strategic advisory, and research. AngeliCo Ventures prides itself on its extensive experience, having completed over $1.6 billion in transactions and raising $465 million for clients. Their approach emphasizes a strong relationship with research institutes and universities, providing early insights into high-potential discoveries. This connection helps AngeliCo Ventures to identify and support promising investment opportunities, guiding companies from inception through various stages of financing and strategic development.

Angelini Ventures is the corporate venture capital arm of Angelini Industries, founded in 2021 and headquartered in Rome, Italy. With a capital commitment of €300 million, Angelini Ventures focuses on early-stage investments in biotechnology, digital health, and life sciences. The firm aims to leverage technology to improve healthcare, reshape patient journeys, and address unmet needs in vulnerable populations. The firm has made significant investments globally, including in Europe, North America, and Israel, with a particular emphasis on brain health and consumer segments such as women, children, and the elderly. Notable portfolio companies include Pretzel Therapeutics, Argobio, Serenis, and Nouscom. Angelini Ventures is led by CEO Paolo Di Giorgio, who has extensive experience in the pharmaceutical and investment sectors. The team includes experts such as Elia Stupka, Managing Director, and Gabriela Manrique, Partner, among others, spread across major innovation hubs globally​.

Angelize is a Berlin-based platform designed for experienced founders across Europe to engage in angel investing. Its mission is to enable successful entrepreneurs to give back to the startup community by investing in the next generation of founders. By fostering a collaborative environment, Angelize helps these "founder-angels" remain active and relevant in the tech ecosystem. The platform simplifies the investment process by providing back-office support, making it easier for founders to focus on mentoring and guiding emerging startups. The program targets founders who have "earned their wings" and are looking for ways to support and mentor other entrepreneurs. Through Angelize, they gain access to a network of like-minded peers and promising startups, creating valuable opportunities for learning, growth, and meaningful impact. With a strong focus on fostering connections across the European tech landscape, Angelize is not just about financial investment but about building long-term relationships between seasoned founders and up-and-coming companies. Angelize stands out by combining financial backing with hands-on mentorship, ensuring that startups not only receive capital but also benefit from the extensive experience and insights of their investors. By bridging the gap between successful founders and new startups, Angelize plays a crucial role in supporting the entrepreneurial ecosystem across Europe.

Angels Santé, established in 2008 and based in Paris, is the largest healthcare-focused business angel network in Europe. It supports early-stage startups in the Biotech, Medtech, and Digital Health sectors, helping bring innovative solutions to market that benefit patients. With over 100 investments made since its inception, the organization fosters partnerships between entrepreneurs and healthcare professionals, providing not only capital but also deep industry expertise in clinical, regulatory, and scientific domains. Each year, Angels Santé finances 10-15 deals, with a focus on Europe, but its reach extends globally through partnerships with organizations like EBAN and Business Angels Europe. This international collaboration allows Angels Santé to facilitate cross-border investments and provide startups with access to a broader market. The network emphasizes a hands-on approach, guiding startups through the complexities of the healthcare landscape by offering mentorship and connections to relevant stakeholders. Notable figures such as Eric Garnier, the president, emphasize the critical role that healthcare innovation plays in solving modern challenges. Furthermore, their US branch, based in Boston, extends opportunities for French-speaking investors in the United States to support healthcare startups with global aspirations. Angels Santé is not just about funding; it's about building a community dedicated to advancing healthcare through innovation, with a long-term commitment to improving patient outcomes and supporting the growth of impactful healthcare companies.

AngelsDeck is a global venture capital network that operates through a unique club model, connecting investors and startups for syndicated investment deals. Founded with the mission to create an international ecosystem for venture deal syndication, AngelsDeck has established itself as a key player in supporting early-stage startups across a variety of industries. With over 14 chapters worldwide and 500 active members, AngelsDeck provides a platform for investors to co-invest in high-growth startups from regions including the US, Europe, the Middle East, and Asia. The firm focuses primarily on seed to pre-Series B companies, with a keen interest in sectors such as technology, healthcare, and sustainability. By leveraging its network of investors, AngelsDeck facilitates joint investments that allow startups to scale quickly while benefiting from strategic mentorship and financial backing. AngelsDeck also runs a startup bootcamp, providing early-stage companies with access to investors and resources to accelerate their growth. One of the unique aspects of AngelsDeck is its ability to create an exclusive and collaborative investment community, where deals are syndicated across its global chapters. This enables investors to pool resources and expertise, speeding up the funding process for startups. AngelsDeck’s investment model emphasizes long-term growth and market expansion, with a clear focus on supporting innovative startups with the potential to disrupt industries.

Anglo Scientific is a venture capital firm that provides management and back-office services to high-tech startups, with a particular focus on artificial intelligence projects since its restructuring in November 2020. The firm, headquartered at The Elms Courtyard in Bromesberrow, UK, assists startups with essential administrative tasks such as payroll, accounts, HR, tax returns, and more, allowing entrepreneurs to focus on innovation and growth. Anglo Scientific has a comprehensive approach to supporting startups, managing tasks that often consume significant time for new businesses. Their portfolio includes companies that benefit from these streamlined services, enabling them to navigate the complexities of early-stage growth and investment readiness​.

Angular Ventures, founded in 2018 and headquartered in London with offices in Tel Aviv and New York, focuses on early-stage enterprise tech companies from Europe and Israel. The firm invests in deep tech sectors including AI, machine learning, developer tools, fintech, and infrastructure. They are known for backing companies with global ambitions and exceptional founding teams. Their portfolio includes companies like JFrog, a developer-focused software company that went public in 2020, and Forter, which provides e-commerce fraud prevention solutions. Aquant, another notable investment, uses AI to provide actionable service intelligence and was acquired by SmartBear. Dust Identity, which utilizes diamond dust for product authentication, recently raised a $40M Series B to expand into new markets. Reco focuses on business and productivity software, emphasizing data security and collaboration. Angular Ventures recently announced a $41M seed fund aimed at supporting enterprise and deep tech startups in Europe and Israel. This fund underscores their commitment to fostering innovation in these regions and sectors, ensuring that promising startups receive the necessary support to scale and succeed globally​.

ANIM is a global venture capital fund with a strong focus on investing in high-growth, innovative companies across various sectors. Based on available information, ANIM targets industries that leverage cutting-edge technologies, though specific sectors or portfolio companies were not clearly outlined. The fund appears to be driven by a mission to back transformative ventures that can scale rapidly, with a global perspective on markets and opportunities. ANIM's strategy seems to include early-stage investments, providing capital and strategic guidance to help startups grow. The fund likely looks for companies with strong leadership, scalability, and market potential. With its emphasis on growth, it’s reasonable to assume that ANIM plays an active role in the businesses it backs, offering more than just financial support. For entrepreneurs seeking investment, the fund might prioritize innovative solutions that have the potential for significant impact, both financially and in terms of market disruption.

Animal Capital, founded in 2020 and based in New York, is a venture capital firm that focuses on investments in consumer technology, financial technology, health and wellness, and media sectors. This firm is distinguished by its unique approach, leveraging the influence of its founders, who are prominent social media stars such as Josh Richards, Griffin Johnson, and Noah Beck, to drive consumer awareness and engagement for its portfolio companies. Notable investments by Animal Capital include Breakr, a platform connecting artists with influencers; Step, a banking app aimed at helping teenagers build credit and learn financial literacy; and Super Coffee, a sugar-free, enhanced coffee brand. Other significant investments include Colossal Laboratories & Biosciences, which focuses on biotechnology, and Zurp, a social platform software company. Animal Capital's strategy involves providing traditional venture capital services such as fundraising and scaling companies, alongside leveraging the founders' broad networks and influence to impact consumer purchasing decisions. This Gen Z-focused approach aims to set new standards in the investment space by effectively tapping into the purchasing power and cultural influence of younger generations.

Animo Ventures is a venture capital firm dedicated to backing early-stage founders who are passionate and willing to go all in. Based in Miami with additional offices in New York and San Francisco, Animo focuses on pre-seed and seed investments in the U.S., cutting checks that range from $500,000 to $2.5 million. The firm actively invests in sectors like fintech, enterprise software, digital health, B2B, and consumer-facing technology, aiming to nurture high-growth startups from ideation to early traction​. What sets Animo apart is its radically founder-focused approach. The firm operates without layers of analysts or associates, meaning founders work directly with general partners throughout the investment process. The team, led by Nico Berardi and Antonio Osio, is deeply involved in all aspects of the startups they back, offering not only capital but also strategic guidance. Animo reserves a significant portion of its fund for follow-on investments, ensuring long-term support​. Animo’s portfolio includes notable companies such as Nearpod, Intello, Morty, and Ironclad, with a particular focus on fintech and enterprise SaaS. The firm is not only a financial backer but also acts as a strategic partner, leveraging a dense network of connections to help with fundraising, hiring, and scaling. With its "people backing people" ethos, Animo builds genuine, long-term relationships with founders, committed to seeing them succeed through every challenge and milestone​.

Ankur Capital is an early-stage venture capital firm based in India, specializing in transformative technologies targeting the next billion people. Founded with a mission to support innovative business models addressing core challenges in sectors such as agriculture, healthcare, education, and fintech, Ankur Capital invests in both digital technology and deep science technology-led companies. Their portfolio includes companies like Cropin, which is driving smart farming; Niramai, pioneering early breast cancer detection with AI; and StringBio, which converts greenhouse gases into value-added proteins. Ankur Capital is dedicated to creating impact through responsible agriculture, climate mitigation and adaptation, and inclusive growth. The firm emphasizes hands-on support, working closely with entrepreneurs from seed to scale. Through their in-house platform, AnkurGro, they provide strategic guidance and operational assistance to help founders navigate their growth journey.

ANOBAKA (formerly KLab Venture Partners) is a Tokyo-based venture capital firm founded in 2015 by Hirokazu Nagano as the investment arm of Japanese online game developer KLab Inc. The firm subsequently rebranded and now operates independently, having separated from its corporate roots to focus exclusively on seed-stage internet and technology startups. A predecessor entity, KLab Ventures, was co-founded with SBI Holdings in 2011 and closed in January 2017. ANOBAKA is among Japan's most active seed investors, with 102 portfolio companies and 239 total investments including follow-on rounds. The firm leads rounds and invests at the pre-seed and seed stages, with average round sizes of $1.35 million at seed and $5.37 million at Series A. The portfolio spans software, SaaS, e-commerce, AI, gaming, and fintech, with investments extending beyond Japan into the United States and Southeast Asia. The firm has raised at least three funds, including ANOBAKA No. 3 Fund and the AI-focused ANOBAKA GAI No. 1. In 2025 alone the firm made 14 investments, with recent portfolio companies including Caper, CORE, prefabdeli.com, and Studio Yurigraph. Ten portfolio exits have been recorded, including fixU (September 2025) and MapleSystems, which was acquired by TWOSTONE&Sons in March 2024. ANOBAKA provides founders with hands-on operational support that extends well beyond capital. The team of six deploys in-house engineers for development consulting, assists with sales strategy, supports international marketing, and provides management guidance throughout the company-building process. This full-stack support model, combined with one of Japan's deepest seed-stage deal networks, positions the firm as a reliable first-check partner for technical founders across the Asia-Pacific region.

Anorak Ventures, founded in 2016 and headquartered in San Francisco, is a seed-stage venture firm that focuses on investing in transformative technology and people. The firm primarily invests in pre-seed and seed-stage companies across various technology sectors, including artificial intelligence and machine learning (AI/ML), Internet of Things (IoT), robotics, and consumer tech. Anorak Ventures has invested in over 120 seed-stage technology companies, which now represent an aggregate market capitalization of $24.8 billion. Notable investments in their portfolio include companies such as Vantage Point, WeatherCheck, Orderful, Framework, Prisms VR, Better Health, and Marxent. They are dedicated to helping these companies achieve product-market fit and secure follow-on financing. The firm, led by Managing Partner Greg Castle, aims to support innovative startups by providing not just capital but also strategic guidance to help them scale and succeed in competitive markets​.

ANRI is a venture capital firm based in Tokyo, Japan, focusing primarily on seed and early-stage investments. Founded with the mission to drive innovation, ANRI has invested in over 260 companies, emphasizing sectors such as electric vehicles, recycling, manufacturing, and information technology. Notable investments by ANRI include startups like Turing, a manufacturer in the electric vehicle sector, and amu, which focuses on recycling and waste management. Their portfolio showcases a strong commitment to diverse industries, including health tech and fintech. ANRI's investment approach often involves co-investing with other significant players in the market, thereby enhancing their portfolio companies' growth and market reach. ANRI has successfully achieved exits with companies like Raksul, DELY, and Coincheck, highlighting their capability to nurture startups towards profitable outcomes. Their investment philosophy emphasizes supporting innovative ideas that have the potential to make substantial impacts globally. The firm is also committed to diversity and inclusion, having set and achieved goals to increase investments in startups led by women. This dedication to fostering a diverse entrepreneurial ecosystem is part of ANRI's broader strategy to drive meaningful change and innovation in the startup landscape​.

Antecedent Ventures is a New York-based seed and early-stage venture capital firm founded in 2015 by Steven Berg, who serves as Founder and Managing Director. The fund focuses on enterprise software, SaaS, and cloud-based applications, backing companies founded by people with deep technical expertise who are solving large, structural problems. Target company profiles include infrastructure platforms, horizontal application layers, and vertical software businesses. Madrona Venture Group is among the firm's top co-investors. The firm invests at seed and Series A stages with checks of $100K to $1 million, deploying into a concentrated portfolio of nine companies. Sectors covered include SaaS, software, data and analytics, and AI. As a solo-GP fund, Antecedent operates lean: Steven Berg is the sole team member, which means founders engage directly with the decision-maker from first conversation through board service. Antecedent Ventures is shaped by a clear thesis: the best enterprise software companies are founded by technical experts who understand the problem at a depth that generalist founders rarely match. Berg looks for companies solving problems that are big enough to anchor a standalone business and where the founding team's domain expertise creates a durable moat. The fund's concentrated portfolio reflects deliberate selectivity — fewer bets, higher conviction, closer engagement with each founding team.

Anterra Capital is a venture capital firm that specializes in investments within the food and agricultural technology sectors. Founded in 2013, Anterra Capital has offices in Amsterdam and Boston and focuses on backing innovative companies that address critical challenges in agriculture, food production, and sustainability. Their portfolio includes notable investments such as Enko Chem, which develops novel crop protection products; ProducePay, a financial and data services platform for the fresh produce industry; and BiomEdit, which focuses on microbiome innovation for animal health. The firm manages over $450 million in assets and typically invests in Series A or B rounds, with initial checks ranging from $1 to $10 million. Anterra is committed to leveraging biotechnology and digital solutions to transform the food system, improve consumer health, and enhance the livelihoods of farmers. Their investment strategy emphasizes impact and sustainability, aligning with their goal to create a resilient and sustainable food system. Anterra Capital has raised significant funds, including a $260 million second Global Food and Agriculture Technology Fund, which continues to support biotech and digital innovations in the agrifood sector​.

Anthem Venture Partners, founded in 2000 and based in Santa Monica, California, is a venture capital firm specializing in early-stage Series A and B investments. The firm primarily focuses on technology companies in Southern California, investing in sectors like software, internet, semiconductors, and new media​. Anthem typically invests between $1 million to $5 million in its portfolio companies and often takes a board seat, indicating a hands-on approach. The firm aims to be the first institutional investor, leading or co-leading the investments. Notable investments by Anthem Venture Partners include Surf Air, indie Semiconductor, Scopely, and Bird Global. The firm has a track record of successful exits, such as the IPO of Surf Air Mobility and the acquisition of Scopely by Savvy Games Group for $4.9 billion​. The team is led by founder and Managing General Partner William Woodward, along with partners like Claudia Llanos and Entrepreneur-in-Residence Sudhin Shahani. The firm's philosophy emphasizes building strong relationships with founders and taking a personal stake in the success of each investment​.

Anthemis Group, founded in 2010 and headquartered in London, is a global investment platform dedicated to fostering innovation in the financial system. The firm focuses on fintech, insurtech, and related sectors, investing from seed to growth stages. Anthemis' portfolio includes notable companies such as Betterment, eToro, and Currencycloud. They also back innovative startups like Pipe, Weavr, and Atomic. With over 150 investments worldwide, Anthemis emphasizes diversity and inclusivity, with 23% of their portfolio companies founded by women and 40% led by women or BIPOC. Their commitment to diversity is further demonstrated through the Female Innovators Lab, which supports female founders in fintech across the UK and Europe. Anthemis recently closed multiple funds totaling over $700 million, expanding their support for fintech companies throughout their lifecycle. The firm also launched an ESG-focused SPAC to advance sustainable finance. Anthemis' thesis-driven approach leverages deep market insights to drive systemic, long-term change. Led by founder Amy Nauiokas and CEO Briana van Strijp, Anthemis is poised to continue its mission of reinventing finance through innovation, collaboration, and inclusivity, supporting the next wave of fintech innovation globally.

Anthill Ventures is a venture capital firm that positions itself as a "speed-scaling" ecosystem, with a focus on helping early-stage startups grow rapidly across multiple sectors, including healthtech, mediatech, urban tech, and consumer tech. Based in Hyderabad, India, with additional offices in Singapore, Anthill provides much more than just capital; it connects startups with corporate partnerships, market access, mentorship, and infrastructure support to scale efficiently. Anthill invests in startups across India, the US, Europe, and Southeast Asia, particularly in sectors that are driving next-generation innovations. Their portfolio includes over 40 startups, ranging from media tech companies to healthcare platforms focused on early cancer detection and smart urban solutions. Some notable companies in their portfolio include Salud, Roadzen, and NAO Spirits. In addition to their core venture fund, Anthill operates several accelerators like Lumos Health and Indus-X, designed to scale companies in healthtech and urban tech, respectively. These programs help startups tap into business networks and expertise in both India and Singapore. Founded by Prasad Vanga, Anthill's team leverages strong international connections to guide startups through scaling challenges, driving impactful growth and fostering innovation across industries.

Anthos Capital, founded in 2007 and based in Santa Monica, California, focuses on growth-stage investments in consumer products, technology, healthcare, and financial services sectors. The firm has made notable investments in companies like Carbon Robotics, known for its Autonomous Weeder which helps reduce reliance on herbicides, and Todyl, a comprehensive cybersecurity platform aimed at small and mid-market businesses. Anthos Capital takes a strategic partnership approach, providing not just capital but also operational and strategic support to help portfolio companies grow and lead their industries. They focus on investments that promise significant growth and impact, supporting companies from early to growth stages with tailored assistance. The firm's recent investment activities include significant funding rounds for companies like Carbon Robotics and Todyl, reflecting their commitment to fostering innovation and industry leadership. Their portfolio showcases a diverse range of companies, emphasizing Anthos Capital's ability to identify and nurture high-potential ventures across various sectors.

Anthro Ventures is an early-stage venture capital firm focused on transforming healthcare and life sciences. The fund aims to improve patient outcomes while simultaneously reducing healthcare costs by investing in innovative, cutting-edge technologies. Anthro Ventures has made notable investments in companies such as Hannah Life Technologies and Ride Health, which align with their goal of addressing unmet clinical needs. Their investment strategy targets early-stage companies—primarily in pre-seed, seed, and Series A rounds. They focus on startups developing impactful medical devices, diagnostics, and digital health solutions. Geographically, their investments span both the U.S. and international markets, including regions like Singapore. Led by managing director Martin Akhavan, Anthro Ventures offers a hands-on approach, guiding their portfolio companies through growth and market dynamics. They tend to favor companies that present a clear path to scalability and that align with their mission of "humanizing healthcare." Startups looking to partner with Anthro should demonstrate both technological innovation and a strong potential to drive down healthcare costs.

Anti Fund, launched in 2021 by Jake Paul and Geoffrey Woo, is a venture capital firm breaking from traditional norms. With a focus on frontier technologies like AI, machine learning, blockchain, and digital health, the fund is built around the philosophy that capital alone isn’t enough—attention and cultural impact are equally critical. Anti Fund's investments include standout startups like Alchemy, Manifold, Osmind, and Moonpay. Based in Miami, the firm targets early-stage ventures, investing between $100,000 and $1 million per deal. Anti Fund primarily backs bold founders who can command attention and challenge industry paradigms. The team uses AngelList’s Rolling Fund model, allowing LPs to subscribe quarterly. Backed by prominent investors such as Marc Andreessen and Chris Dixon, the fund has gained quick traction. The fund’s strategy is centered on reshaping the cultural landscape, blending capital with the founders' ability to create significant market demand. This unique approach reflects both Paul’s background in entertainment and Woo’s expertise in tech entrepreneurship.

Antler is a globally renowned early-stage venture capital firm known as the "day zero investor," backing founders from the inception of their startups. With over 850 investments in 20+ countries, Antler has notable portfolio companies like Airalo, a global eSIM provider, and has recently raised a $60 million MENAP fund to further support startups in the Middle East, North Africa, and Pakistan region. Antler focuses on sectors including technology, fintech, and digital innovation, providing personalized coaching, co-founder matching, and follow-on funding. Key team members include Dr. Jonathan Doerr and Romain Assunção, leading regional activities from Riyadh and Duba

ANU Connect Ventures is a Canberra, Australia-based venture capital firm founded in 2005 with a mandate to commercialize research from The Australian National University, the University of Canberra, and Charles Sturt University. The firm supports university research with commercial potential in proof-of-concept work, then invests in the most promising opportunities emerging from ACT-based academic institutions and local R&D companies. Two funds are under management: the Discovery Translation Fund and a $37 million Seed Investment fund structured as the ANU-MTAA Super Venture Capital Partnership. A team of seven — including two partners and three principals — has built a portfolio of nine companies primarily in life sciences and enterprise technology over more than twelve years of active investing. The firm leads rounds at pre-seed and seed stages, deploying $500K to $3 million per investment. Sectors include biotech, deep tech, software, and health technology, reflecting the research strengths of its university partners. ANU Connect Ventures occupies a critical position in Australia's innovation pipeline: bridging the gap between academic discovery and commercial application in a region where startup infrastructure has historically been limited. By anchoring its mandate to world-class research institutions, the firm sources differentiated deal flow that is difficult to access through conventional venture channels. Its patient, commercialization-focused approach serves founders who are translating scientific breakthroughs into viable businesses for the first time.

Anyon is a Germany-based venture capital firm focused on investing in early-stage technology companies that are digitizing the real estate industry. Established in 2016, Anyon operates with offices in Berlin, Frankfurt, and Munich. The firm primarily targets PropTech and IoT startups that aim to modernize real estate operations and management. Leveraging their expertise in real estate, Anyon partners with entrepreneurs to help them scale by offering strategic support, operational insights, and access to their network of industry experts. Anyon typically invests in pre-seed and seed-stage startups with ticket sizes ranging from €100k to €1.5 million. Their portfolio includes companies like Thing-it, an IoT platform for managing smart buildings, and Alasco, a construction management software designed to streamline financial processes in real estate projects. Anyon’s investment approach is deeply integrated with their platform, allowing startups to benefit from shared resources and technology infrastructure, driving value creation in their portfolio. The firm is led by founding partners Rupprecht Rittweger and Dr. Dennis Lips, who combine decades of experience in real estate and technology to guide the companies they back toward long-term growth and success.

ANZi Ventures — now operating as 1835i — is the corporate venture capital and incubator arm of ANZ Group Holdings, one of Australia's four major banks. Founded in Melbourne in 2018, the unit was established as a standalone entity to accelerate ANZ's digital transformation and develop new financial propositions. The name 1835i honors the bank's nearly 200-year history, tracing to The Bank of Australasia established under Royal Charter in 1835. Managing Director Ron Spector leads the unit alongside three appointed partners drawn from ANZ and the broader startup community. With approximately $275 million deployed to date across 17 investments, the firm focuses on fintech, open banking, payments, and digital lending at Series A through growth stages, writing checks of $3 million to $50 million and leading rounds. Portfolio highlights include Airwallex — the foreign exchange unicorn — and Lendi Group, a digital home loan origination platform, alongside companies spanning cashback, data collaboration, loan marketplaces, and payment infrastructure. 1835i differentiates itself from generalist CVCs through its deep alignment with ANZ's commercial banking operations: portfolio companies gain access to the bank's customer base, financial infrastructure, and regulatory relationships across Australia and Southeast Asia. Rather than passive minority stakes, the firm pursues active engagement with founders to co-develop products and propositions that serve ANZ's millions of retail and business customers.

Anzu Partners is a venture capital firm founded in 2014, focusing on breakthrough industrial and life sciences technologies. Headquartered in Washington, D.C., with additional offices in Boston, San Diego, and Tampa, the firm manages over $1 billion in strategic assets across various funds and investment strategies. Anzu Partners has a robust portfolio of around 40 companies, including notable investments in e-Zinc, Framework, EnCharge, AM Batteries, and Arduino. The firm has also achieved significant exits, such as NUBURU and Ai-Media, highlighting its capability to support companies from early stages through to successful public offerings or acquisitions. Anzu specializes in three primary investment solutions: venture capital investments, debt and revenue-based investments, and Special Purpose Acquisition Companies (SPACs). The firm provides not just capital but also deep expertise in business development, market positioning, global connectivity, and operations, helping to drive the commercial success of its portfolio companies. The leadership team at Anzu Partners includes experienced professionals like Managing Partners David Michael, David Seldin, and Whitney Haring-Smith, who bring decades of combined experience in global investments and consultancy. This expertise is further supported by a dedicated team of technical and operational professionals.

Aonia Ventures is a Paris-based micro-VC firm founded in 2020 with roots in Switzerland, investing in 20 to 30 technology startups per year worldwide at seed and Series A stages. The firm deploys €100K to €250K per deal across healthtech, fintech, greentech, foodtech, wellness, and lifestyle — sectors where Aonia sees urgent problems and scalable solutions converging. A team of three partners runs the fund, maintaining a high-volume, hands-on investment cadence across Europe and the United States. With 55 portfolio companies and counting, Aonia has accumulated a track record that includes one unicorn — Alan, the French health insurance platform — and one public market exit via Field Trip Health and Wellness. These outcomes anchor the portfolio's credibility against a backdrop of broad, consistent early-stage deployment across multiple sectors and geographies. Aonia's model is deliberately high-frequency: by writing smaller checks across a large number of bets each year, the firm maximizes exposure to breakout outcomes while building a portfolio network with compounding cross-sector value. The fund's particular strength in health and wellness, combined with greentech and fintech coverage, reflects founders' growing interest in businesses that address large systemic challenges — a thesis Aonia has pursued since its founding and continues to refine with each cohort of investments.

AP Capital is a diversified investment firm with a strong presence in global markets, including equities, commodities, foreign exchange, and fixed income. Headquartered in Asia and Los Angeles, the firm specializes in proprietary trading and asset management. AP Capital aims to achieve consistent net-positive returns while minimizing market risks, making it a go-to choice for high-net-worth individuals, family offices, and institutional investors across Asia, Europe, and North America. The firm's investment strategy emphasizes a low correlation to broader market fluctuations, leveraging cutting-edge technology for its trading operations. AP Capital offers discretionary fund products and managed accounts, allowing investors greater transparency and control over their portfolios. Their diverse approach spans multiple industries, including real estate, renewable energy, and tech. With a focus on risk-adjusted returns and liquidity improvement, AP Capital has built a reputation for being nimble and adaptable, thanks to its young, energetic, and meritocratic team culture.

APA Venture Partners is a San Francisco-based pre-seed and seed-stage venture capital firm founded in 2020, focused on founders who are automating legacy industries. The firm targets healthcare, B2B SaaS, and consumer technology — sectors where outdated processes create substantial displacement opportunity for technology-led challengers. APA was founded by individuals with significant institutional VC and company-building experience, combining that background with high-touch operational support and curated access to Fortune 500 companies. The firm leads rounds and typically writes checks of $100K to $1 million, with 16 investments to date across its target sectors. Portfolio companies include DataPlor, a location intelligence data company, alongside other early-stage businesses in logistics and consumer mobility. APA invests exclusively in the United States, maintaining a national scope while operating from its San Francisco base. APA Venture Partners calls its target founders 'rule-breakers' — operators who have identified inefficiencies in established industries and possess the domain expertise to replace incumbent processes with better technology. The firm's value proposition extends well beyond capital: the team provides hands-on operational guidance and broker introductions to major corporate partners, giving portfolio companies a meaningful commercial runway advantage in the earliest, most fragile stage of company building.

Apax Partners is a leading global private equity advisory firm with a focus on inspiring growth and transforming businesses. Founded nearly 50 years ago, Apax has raised and advised over 30 funds, managing more than $77 billion in aggregate capital. The firm primarily invests in four sectors: Tech, Services, Healthcare, and Internet/Consumer. Apax operates several strategic funds, including Apax Global Buyout, which focuses on transformative growth in key sectors, and Apax Digital Growth, aimed at accelerating tech companies. Additionally, Apax Global Impact targets companies that deliver tangible societal and environmental benefits, while Apax Mid-Market Israel leverages local expertise to support growth in Israeli businesses. The firm also has Apax Credit and Apax Listed Private Equity strategies to provide a flexible investment approach across the capital structure​. Notable investments include Auto Trader Group, GlobalLogic, and Cole Haan, among others. Apax leverages its deep sector expertise and global network to drive operational excellence and digital transformation within its portfolio companies. The firm’s extensive experience and strategic focus have made it a prominent player in private equity globally, with offices in major financial hubs including London, New York, Hong Kong, and Tel Aviv​.

Aper Ventures is a Warsaw, Poland-based venture capital firm founded in 2014 — originally as Meta Ventures, rebranded to Aper Ventures in 2019 — focused exclusively on deep tech and hardware startups at the onset of commercialization. With approximately PLN 130 million (roughly €30 million) in assets under management, including PLN 50 million deployed since 2019, the firm is co-financed by PFR Ventures, the Polish Development Fund. Four partners lead the team of five, targeting investments of €1 to €5 million per company at seed and Series A stages. Aper leads rounds and has invested in 25 companies across hardware and robotics, deep tech, clean technology, and software. Portfolio companies include Reef Factory, Maas Loop, and AP-Tech. The firm's target profile is a startup where technological risk is declining and the primary challenge has shifted to scaling hardware production and entering commercial markets — a transition that requires capital plus operational expertise. Aper Ventures addresses a genuine gap in the European venture landscape: most generalist VCs lack the patience and technical judgment required to back hardware at the commercialization threshold, where unit economics are still maturing but the technology is proven. The firm's narrow focus allows it to develop deep competency in exactly this transition — supporting founders through the demanding shift from prototype to repeatable product at scale across Central and Eastern Europe.

Aperture Venture Capital (Aperture VC) is a venture capital firm founded in 2021, based in Radnor, Pennsylvania. The firm focuses on investing in early-stage companies, particularly those led by diverse founders who are building the future of fintech and enterprise software. Aperture VC's mission is to redefine the venture capital landscape by supporting the "Multicultural Mainstream," which includes Black, Latinx, and female entrepreneurs. Aperture VC’s unique approach involves its Diversity Investing API℠, a platform designed to connect corporate partners with diverse talent and market innovations. This platform also provides portfolio companies with critical operating resources to help them scale. The firm believes that by investing in diverse founders, they can unlock untapped potential and drive significant impact in the venture capital ecosystem. Aperture VC has quickly gained recognition in the industry, attracting investments from major corporations like PayPal, which have recognized the value of supporting diverse founders. The firm is committed to fostering an inclusive ecosystem where diverse entrepreneurs can thrive and achieve successful exits.

APEX Ventures is a venture capital firm based in Vienna, Austria, specializing in deep tech and medical technology startups. Founded in 2016, APEX Ventures invests in early-stage companies across Europe, with a focus on innovations in AI, quantum computing, automation, robotics, computer vision, space technology, and medical technology. The firm emphasizes backing startups with unique, defensible technologies that have the potential to disrupt and transform their respective industries​. In 2023, APEX Ventures partnered with Amadeus Capital Partners to launch the Amadeus APEX Technology Fund, which aims to raise €80 million to support deep tech startups primarily in the DACH region (Germany, Austria, and Switzerland). This fund focuses on seed and Series A investments, typically ranging from €1 million to €1.5 million. The partnership combines APEX’s local expertise and network with Amadeus’ extensive global experience in venture capital. APEX Ventures has a diverse portfolio, including companies like contextflow, ImageBiopsy Lab, and Mobius Labs. The firm is known for providing not just capital but also strategic support, leveraging their deep tech expertise and strong networks to help startups scale and succeed​.

Apollo Global Management, a leading global alternative investment manager, has a diverse and extensive portfolio across various sectors. As of 2024, Apollo manages approximately $548 billion in assets, with substantial investments in private equity, credit, and real estate. In the private equity space, Apollo's portfolio includes companies like ADT Inc., a major provider of security and automation solutions; CareerBuilder, an online employment service; and The Fresh Market, a specialty grocery retailer. They also have significant holdings in the healthcare sector with companies like LifePoint Health and R1 RCM Inc. Apollo is known for its strategic acquisitions across multiple industries. Notable recent acquisitions include U.S. Silica, a producer and supplier of silica sand, and Modern Aviation, a premium aviation services provider. Additionally, Apollo has made significant investments in the travel and hospitality sector, exemplified by its acquisition of Great Wolf Resorts and Diamond Resorts International. The firm's investment strategy focuses on creating value through buyouts, corporate carve-outs, and distressed asset investments. This approach has enabled Apollo to build a robust portfolio that spans various geographies, primarily the United States and the United Kingdom, with a strong presence in the energy and financial services sectors.

Apollo Projects, spearheaded by the Altman brothers—Sam, Jack, and Max—is a venture capital firm that specializes in funding transformative, early-stage companies. With a focus on "moonshots," Apollo targets startups with the potential to disrupt industries and create significant societal impact. Their portfolio boasts notable investments like KoBold Metals, which uses artificial intelligence for mineral exploration, and Glydways, a revolutionary transportation company. Apollo Projects is particularly active in sectors such as AI, renewable energy, and advanced biotechnology, where innovation can drive profound change. The firm typically leads funding rounds, writing substantial checks to support the ambitious goals of its portfolio companies. Apollo's investment strategy is centered around identifying and nurturing startups that are not only innovative but also have a clear vision for large-scale impact. They are especially interested in companies that challenge the status quo and push the boundaries of technology and industry norms. With a seasoned team led by the Altman brothers—each bringing a wealth of experience from their diverse backgrounds—Apollo Projects offers more than just capital. They provide strategic guidance and a deep network of industry connections, making them an invaluable partner for startups aiming to scale quickly and effectively. Entrepreneurs with bold, disruptive ideas often find Apollo Projects to be an ideal ally in their journey to bring groundbreaking technologies to market. This combination of financial backing, expertise, and a shared vision for the future positions Apollo Projects as a pivotal force in the venture capital landscape.

Apollo Health Ventures is a transatlantic venture capital firm founded in 2016 and headquartered in Berlin, Germany. Co-founded and led by Managing Director Nils Regge, the firm's singular mission is to fund and co-build companies that target the root causes of aging and age-related diseases. Apollo focuses on breakthrough science in Alzheimer's disease, heart disease, cancer, sarcopenia, and frailty — with the ultimate goal of extending healthy human lifespan. The firm takes an active company-building role, frequently co-founding portfolio companies alongside scientists and entrepreneurs. Apollo leads rounds and has made approximately 13 investments across Seed and Series A stages, with seed rounds averaging $9.7 million and Series A rounds averaging $34 million. Notable portfolio companies include Auron Therapeutics, HAYA Therapeutics, Cleara Biotech, Cognito Therapeutics, and Aeovian Pharmaceuticals. The portfolio spans the United States and Europe, reflecting the firm's transatlantic orientation and its Bio Fund I structure. Apollo Health Ventures differentiates itself through its company-building model: the team does not passively invest in existing longevity companies but actively participates in their creation, recruiting scientists, shaping research strategy, and guiding early clinical positioning. This founder-in-residence approach concentrates portfolio expertise in a narrow therapeutic category and allows Apollo to shape the science from the earliest stages — well before most investors enter the conversation.

Appian Education Ventures is a global leader in building innovative, investor-backed educational enterprises. Founded by Luis García de Brigard, a former Deputy Minister of Education in Colombia, Appian is dedicated to transforming the education sector through cutting-edge solutions that foster sustainable and impactful learning environments. With offices in Boston, Miami, Madrid, Bogotá, and Abu Dhabi, the firm operates across a wide geographic footprint, reflecting its mission to expand access to quality education worldwide. Appian specializes in developing educational ventures that integrate technology and robust curricula, aiming to improve educational outcomes. Their approach includes partnering with educators, policymakers, and investors to create transformative learning models. With a focus on outcome-based innovations, Appian ensures that technological advancements in education are effectively implemented to foster academic success and personal growth. The firm's leadership brings decades of expertise from sectors like education, government, and business. Founder Luis García de Brigard has extensive experience in both public policy and educational entrepreneurship. Other key members include former consultants and executives from top firms like McKinsey & Company, Bain & Company, and Accenture, all of whom bring a wealth of strategic knowledge to the firm. This combination of educational insight and business acumen enables Appian to drive large-scale educational improvements globally. Through its ventures, Appian provides comprehensive services, including curriculum development, school management, and advisory support for educational technology. Its global reach and expert team make it a key player in reshaping education for the 21st century​.

Apple Tree Partners (ATP) is a distinguished venture capital firm focused on life sciences, founded in 1999 by Dr. Seth Harrison. With offices in New York, San Francisco, and Cambridge, ATP has committed $2.9 billion in capital, making it one of the key players in biotech venture investing. The firm’s approach is unique in that it both creates and invests in companies, often starting from early-stage scientific ideas or asset spinouts from other companies. ATP provides flexible capital and strategic support to foster the development of science-driven enterprises. The firm is involved in every stage of a company’s life cycle, from seed investments to IPO and beyond. Notably, ATP has been instrumental in launching over 30 life sciences companies, of which 19 have gone public or been acquired. Some successful portfolio companies include Chinook Therapeutics, Akero Therapeutics, and Stoke Therapeutics​. In addition to financial backing, ATP brings operational expertise to its portfolio companies, helping them navigate clinical trials, regulatory processes, and market entry strategies. The firm has pioneered advancements in fields such as oncology, metabolic diseases, and inflammatory disorders, combining deep scientific understanding with entrepreneurial rigor. ATP’s investments, including its recent creation of Deep Apple Therapeutics, exemplify its commitment to using cutting-edge technologies like AI and machine learning to accelerate drug discovery and deliver life-changing therapies.

Applied Ventures is the venture capital arm of Applied Materials, based in Santa Clara, California. Since its establishment in 2006, the firm has focused on early-stage investments, primarily within deep technology sectors such as semiconductors, energy, advanced materials, and life sciences. Applied Ventures has a global reach, with investments spanning across North America, Europe, Asia-Pacific, and the Middle East. The firm is known for its flexibility, investing up to $100 million annually and actively participating in funding rounds ranging from $10 to $50 million. Its strategy emphasizes supporting startups with disruptive technologies by connecting them to Applied Materials' global ecosystem, which includes industry partners, supply chain resources, and technical expertise. Key portfolio companies include Ayar Labs (optical I/O technology), Rockley Photonics, and TXOne Networks, reflecting its focus on innovations that align with Applied Materials' core strengths in materials engineering and semiconductor technology​. The investment team is led by Anand Kamannavar, who serves as Global Head, alongside key figures such as Brad McManus, John Wei, and Rajesh Ramanujam, all based in Santa Clara. Applied Ventures is stage-agnostic, supporting both early and growth-stage startups as they scale globally, especially those involved in deep tech advancements.

Apposite Capital is a London-based venture capital firm specializing in the healthcare sector. Founded in 2006, the firm focuses on investing in innovative healthcare companies across the UK and Europe. Apposite Capital provides a mix of venture, development, and growth financing, along with buyout capital, primarily targeting companies that can significantly impact healthcare through improved services and technologies. Their investment strategy emphasizes supporting companies with scalable business models and strong growth potential. Apposite Capital has a track record of successful investments in healthcare services, medical devices, diagnostics, and digital health. The firm typically takes an active role in its portfolio companies, providing strategic guidance and leveraging its extensive network within the healthcare industry to drive growth and innovation. Apposite Capital's team brings a combination of operational, scientific, and financial expertise, allowing them to deeply understand and support the unique needs of healthcare businesses. They also focus on promoting best practices in environmental, social, and governance (ESG) and are committed to making a positive impact through their investments. Recent notable investments include companies like NIMGenetics, HCML, and Emblation, showcasing their commitment to advancing healthcare solutions and improving patient outcomes​.

APX is a Berlin-based venture capital firm that focuses on pre-seed investments, supporting startups at the earliest stages. Founded in 2018 as a joint venture between Axel Springer and Porsche, APX is known for backing digital business models and exceptional founding teams across Europe. It has invested in over 185 companies, spanning industries such as fintech, SaaS, consumer services, and mobility. APX is committed to being a long-term partner, often serving as the first investor for many startups. They typically provide initial funding up to €500,000, with follow-on support available as companies grow. In 2023, they launched HEARTFELT, a new fund focused on continuing early-stage investments while managing their existing portfolio. With a hands-on approach, APX offers not just capital but also guidance on sales, operations, and strategic partnerships. Their network of experienced investors and successful entrepreneurs plays a key role in helping startups scale.

Aqua-Spark, based in the Netherlands, is a global investment fund dedicated to sustainable aquaculture. Founded in 2013 by Mike Velings and Amy Novogratz, the fund aims to transform the aquaculture industry by promoting environmental and social sustainability alongside financial returns. Aqua-Spark's mission is to make the production of aquatic life such as fish, shellfish, and plants safe, accessible, and environmentally friendly. The fund manages around $450 million in assets and has invested in 24 companies across the aquaculture value chain, aiming to expand its portfolio to 50-60 companies. Some notable investments include eFishery, an Indonesian aquaculture tech startup, Calysta, a biotech company producing sustainable feed ingredients, and Wanda Fish, which is developing cultivated bluefin tuna. Aqua-Spark focuses on early-stage investments, typically at the Series A stage, and supports companies through to maturity. Their investments are chosen for their potential to generate significant environmental and social impacts while delivering solid financial returns. The fund has a diverse investor base of around 300 investors from over 25 countries.

Aquarius Equity is a UK-based venture capital firm with a strong focus on early-stage investments in high-growth companies, particularly those located in the North of England. The firm, established to bridge the venture capital gap in this region, is dedicated to supporting innovative startups that have the potential to scale significantly. Their latest fund, the Aquarius Origin Fund, targets investments of up to £750,000, focusing on sectors like biotechnology, life sciences, and technology. Aquarius Equity's investment strategy emphasizes scalability and sustainability, with a particular interest in companies that align with the UN Sustainable Development Goals. They seek out companies with proven business models and significant growth potential, especially those that have already secured investment from industry-recognized investors. The firm also encourages investments from private individuals through Self Invested Personal Pension (SIPP) schemes, allowing them to invest in early-stage companies traditionally dominated by institutional funds. Aquarius Equity is not just a financial backer but also an active partner, providing strategic support to help startups achieve their growth ambitions. The firm’s commitment to innovation and sustainability positions it as a key player in the venture capital landscape, particularly in the UK’s underserved Northern regions.

Aquilo Capital Management is a biotech-focused investment firm based in San Francisco, established in 2010. The firm specializes in funding drug development companies that utilize cutting-edge science to address urgent medical needs. Aquilo’s approach is rooted in deep sector expertise and a disciplined, value-oriented investment strategy. They focus on identifying biotech companies with the potential to create transformative therapeutics that can significantly impact healthcare and society. The firm’s investment strategy is heavily concentrated in life sciences, targeting innovative drug discovery and development projects. They aim to balance risk with high potential returns, favoring companies that are on the cusp of delivering paradigm-shifting treatments. Aquilo employs both a long-only and hedged investment strategy, giving them flexibility and resilience in volatile markets. Notable investments include pioneering biotech firms like Arrowhead Pharmaceuticals and Regenxbio. Aquilo Capital is led by founder and CIO Marc Schneidman, who brings over 20 years of experience in the biotech investment space. The firm takes a global perspective, with a keen interest in leveraging opportunities in both the U.S. and Europe. They are known for supporting early-stage ventures and maintaining strong relationships with the scientific and biotech communities. Aquilo’s mission is to bridge the gap between groundbreaking science and successful commercial application, delivering both societal benefits and strong returns for investors.

marArali Ventures, founded in 2017 and based in Bangalore, India, is a venture capital firm focused on early-stage investments in enterprise tech startups. The firm primarily targets companies in India but has also invested in the United States and Singapore. Their investment strategy includes sectors such as artificial intelligence, fintech, healthtech, and high tech. Notable investments by Arali Ventures include Wingman, a conversational AI for sales, and Insent, a B2B enterprise sales platform acquired by ZoomInfo in 2021. Other significant investments include Protecto in business services and Wiz Freight in logistics tech​. Arali Ventures has made 28 investments to date and has achieved notable exits with companies like Insent and Wingman. The firm is currently raising its second seed fund, aiming for $30-40 million, to continue supporting startups in SME tech, industrial automation, and robotics​. Their team, led by Managing Partner Rajiv Raghunandan, provides extensive support to portfolio companies, emphasizing a hands-on approach and deep industry expertise. This supportive environment has made them a highly founder-friendly VC firm.